Are there any differences in the clinical and economic outcomes between US cancer patients receiving appropriate or inappropriate venous thromboembolism prophylaxis?

Journal of Oncology Practice

Volumn 5, Issue 4, 2009, Pages 159-164

  Amin, Alpesh N ^a   Lin, Jay ^a   Yang, Guiping ^a   Stemkowski, Stephen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CANCER PATIENT; CLINICAL FEATURE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HOSPITAL COST; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PATIENT SAFETY; PRIMARY TUMOR; PROPHYLAXIS; THERAPY EFFECT; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 74749083442     PISSN: 15547477     EISSN: None     Source Type: Journal    
DOI: 10.1200/JOP.0942002     Document Type: Article

References (19)

1. Heit JA, Mohr DN, Silverstein MD, et al: Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study. Arch Intern Med 160:761-768, 2000
2. Blom JW, Vanderschoot JP, Oostindier MJ, et al: Incidence of venous thromboembolism in a large cohort of 66,329 cancer patients: Results of a record linkage study. J Thromb Haemost 4:529-535, 2006
3. Khorana AA, Francis CW, Culakova E, et al: Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24:484-490, 2006
4. Stein PD, Beemath A, Meyers FA, et al: Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 119:60-68, 2006
5. Donati MB: Cancer and thrombosis. Haemostasis 24:128-131, 1994
6. Kuderer NM, Khorana AA, Lyman GH, et al: A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: Impact on survival and bleeding complications. Cancer 110:1149-1161, 2007
7. Geerts WH, Pineo GF, Heit JA, et al: Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:338S-400S, 2004 (suppl 3)
8. Geerts WH, Bergqvist D, Pineo GF, et al: Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:381S-453S, 2008 (suppl 6)
9. Lyman GH, Khorana AA, Falanga A, et al: American Society of Clinical Oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25:5490-5505, 2007
10. National Comprehensive Cancer Network: Venous thromboembolic disease clinical practice guidelines in oncology. http://www.nccn.org
11. Kakkar AK, Levine M, Pinedo HM, et al: Venous thrombosis in cancer patients: Insights from the FRONTLINE survey. Oncologist 8:381-388, 2003
12. Burleigh E, Wang C, Foster D et al: Thromboprophylaxis in medically ill patients at risk for venous thromboembolism. Am J Health Syst Pharm 63:S23-S29, 2006 (suppl 6)
13. Amin A, Stemkowski S, Lin J, et al: Thromboprophylaxis rates in US medical centers: Success or failure? J Thromb Haemost 5:1610-1616, 2007
14. Samama MM, Cohen AT, Darmon JY, et al: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 341:793-800, 1999
15. McGarry LJ, Thompson D: Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice. Clin Ther 26:419-430, 2004
16. Cohen AT, Tapson VF, Bergmann JF, et al: Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study. Lancet 371:387-394, 2008
17. ENOXACAN Study Group: Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. Br J Surg 84:1099-1103, 1997
18. Bergqvist D, Agnelli G, Cohen AT, et al: Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346:975-980, 2002
19. Tooher R, Middleton P, Pham C, et al: A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 241: 397-415, 2005